Brown Advisory Securities, LLC - TEVA PHARMACEUTICAL FIN LLC ownership

TEVA PHARMACEUTICAL FIN LLC's ticker is and the CUSIP is 88163VAE9. A total of 62 filers reported holding TEVA PHARMACEUTICAL FIN LLC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
Brown Advisory Securities, LLC ownership history of TEVA PHARMACEUTICAL FIN LLC
ValueSharesWeighting
Q3 2017$22,0000.0%22,0000.0%0.01%0.0%
Q2 2017$22,000
+37.5%
22,000
+37.5%
0.01%
+25.0%
Q1 2017$16,000
+23.1%
16,000
+33.3%
0.00%0.0%
Q4 2016$13,0000.0%12,000
+9.1%
0.00%0.0%
Q3 2016$13,000
-13.3%
11,000
-8.3%
0.00%
-20.0%
Q2 2016$15,000
-28.6%
12,000
-25.0%
0.01%
-28.6%
Q1 2016$21,000
-22.2%
16,000
-5.9%
0.01%
-22.2%
Q4 2015$27,000
+17.4%
17,0000.0%0.01%
+12.5%
Q3 2015$23,0000.0%17,0000.0%0.01%0.0%
Q2 2015$23,000
+9.5%
17,000
+13.3%
0.01%
+14.3%
Q1 2015$21,000
-19.2%
15,000
-21.1%
0.01%
-22.2%
Q4 2014$26,000
+13.0%
19,000
+11.8%
0.01%
+12.5%
Q3 2014$23,0000.0%17,0000.0%0.01%0.0%
Q2 2014$23,000
+21.1%
17,0000.0%0.01%
+14.3%
Q1 2014$19,000
+5.6%
17,000
-5.6%
0.01%0.0%
Q4 2013$18,000
-10.0%
18,000
-10.0%
0.01%
-22.2%
Q3 2013$20,000
-9.1%
20,000
-9.1%
0.01%
-18.2%
Q2 2013$22,00022,0000.01%
Other shareholders
TEVA PHARMACEUTICAL FIN LLC shareholders Q4 2017
NameSharesValueWeighting ↓
Southpaw Asset Management LP 20,000,000$17,675,00025.38%
INCOME RESEARCH & MANAGEMENT 23,109,000$20,278,0005.29%
Fore Capital, LLC 5,000,000$4,430,0001.71%
RIVERHEAD CAPITAL MANAGEMENT LLC 20,000,000$17,603,0000.74%
ARISTEIA CAPITAL, L.L.C. 18,500,000$16,361,0000.70%
ZAZOVE ASSOCIATES LLC 11,153,000$9,843,0000.58%
BASSO CAPITAL MANAGEMENT, L.P. 3,600,000$3,182,0000.52%
CSS LLC/IL 10,450,000$9,240,0000.45%
Lombard Odier Asset Management (Europe) Ltd 7,950,000$7,038,0000.44%
Wellesley Asset Management 6,740$5,948,0000.31%
View complete list of TEVA PHARMACEUTICAL FIN LLC shareholders